investigate the effect of vitamin B 1 on menstrual bleeding and spotting after insertion of the IUD.
This study will be randomized controlled trial will be performed at the Obstetric and Gynecological Department at Beni-Suef University Hospital, Faculty of Medicine Target Population: All females with first time use of IUD inserted at the Obstetrics and Gynecology department through 3 months from the start of July 2023 till the end of November 2023. Participants will be assigned in a 1:1 ratio to the use of vitamin B 1 or placebo, in accordance with a random table produced by an Excel program, with A being assigned to the intervention group and B to the control group. All women will sign a written informed consent prior to data collection. Each woman within the intervention group will receive a packet containing 30 pills (vitamin B 1 or placebo), each month for three months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
VITAMIN B1 (High Potency) 500mg tab every day for 3 months
intra-uterine contraceptive device
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt
the duration of menstrual bleeding.
days of menstruation
Time frame: 3 cycles ( 3 months / one month for each cycle)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.